Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anne Keller, MD
Princess Margaret Hospital, Canada
Principal Investigator - Bayardo Perez-Ordonez, MD
Princess Margaret Hospital, Canada
Principal Investigator - Chu-Shu Gu, M.Sc.
Ontario Clinical Oncology Group (OCOG)
Principal Investigator - John Waldron, MD
Princess Margaret Hospital, Canada
Study Chair - Libni Eapen, MD
Ottawa Regional Cancer Centre
Principal Investigator - Mark N Levine, MD
Ontario Clinical Oncology Group (OCOG)
Principal Investigator - Ralph Gilbert, MD
Princess Margaret Hospital, Canada
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- London Regional Cancer Centre
London, Ontario, Canada
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2004
- Primary completion
- 31 Aug 2009
- Completion
- 31 May 2011
- Last update posted
- 22 Jun 2012
- Registered enrollment
- 400
- Registry id
- NCT00147472
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.